During the past decade, Japanese Red Cross Kyoto Daini Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Japanese Red Cross Kyoto Daini Hospital" #1 sponsor was "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 4 trials, followed by "Astex Pharmaceuticals, Inc." with 2 trials sponsored, "Ministry of Health, Labour and Welfare, Japan" with 2 trials sponsored, "Associations for Establishment of Evidence in Interventions" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Japanese Red Cross Kyoto Daini Hospital" #1 collaborator was "Maruishi Pharmaceutical" with 2 trials as a collaborator, "Niigata University Medical & Dental Hospital" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 1 trials as a collaborator and "Mitsubishi Tanabe Pharma Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Japanese Red Cross Kyoto Daini Hospital" are "Acute Myeloid Leukemia" (2 trials), "Colorectal Cancer" (2 trials), "Gastrointestinal Stromal Tumor" (2 trials), "Metastatic Cancer" (2 trials) and "Sedation" (2 trials). Many other conditions were trialed in "Japanese Red Cross Kyoto Daini Hospital" in a lesser frequency.

Most popular intervention types in "Japanese Red Cross Kyoto Daini Hospital" are "Drug" (12 trials), "Biological" (1 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "UFT adjuvant chemotherapy" (2 trials), "Any approved or standard-of-care therapy" (1 trials), "Blopress (Candesartan)" (1 trials) and "Cypher stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Japanese Red Cross Kyoto Daini Hospital" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Japanese Red Cross Kyoto Daini Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Japanese Red Cross Kyoto Daini Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Japanese Red Cross Kyoto Daini Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".